Brief: Guardant Health Q3 Adjusted EPS USD -0.45 Vs. IBES Estimate USD -0.74
06/11/2024 21:05
Nov 06 (Reuters) - Guardant Health Q3 EPS USD -0.88. * Q3 adjusted net income USD -55 million vs. IBES estimate USD -95.2 million * Q3 revenue USD 191.5 million vs. IBES estimate USD 170.6 million * Q3 adjusted EBITDA USD -56.2 million vs. IBES estimate USD -66.4 million * outlook FY revenue USD 720-725 million
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte